BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35460900)

  • 1. Summary of the FDA virtual public workshop on spinal device clinical review held on September 17, 2021.
    Devlin VJ; Jean R; Peat CR; Jiang H; Anderson PA; Benson JC; Brodke DS; Golish SR; Kebaish KM; Larson AN; Serhan H
    Spine J; 2022 Sep; 22(9):1423-1433. PubMed ID: 35460900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical devices: US medical device regulation.
    Jarow JP; Baxley JH
    Urol Oncol; 2015 Mar; 33(3):128-32. PubMed ID: 25458071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA Regulation and Approval of Medical Devices: 1976-2020.
    Darrow JJ; Avorn J; Kesselheim AS
    JAMA; 2021 Aug; 326(5):420-432. PubMed ID: 34342614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal devices in the United States-investigational device exemption trials and premarket approval of class III devices.
    Golish SR; Reed ML
    Spine J; 2017 Jan; 17(1):150-157. PubMed ID: 27737804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(10):2296-323. PubMed ID: 11010655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory Considerations for Physiological Closed-Loop Controlled Medical Devices Used for Automated Critical Care: Food and Drug Administration Workshop Discussion Topics.
    Parvinian B; Scully C; Wiyor H; Kumar A; Weininger S
    Anesth Analg; 2018 Jun; 126(6):1916-1925. PubMed ID: 28763355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical devices; exemption from premarket notification and reserved devices; Class I--FDA. Proposed rule.
    Fed Regist; 1998 Nov; 63(218):63222-53. PubMed ID: 10187398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Software-Related Recalls of Health Information Technology and Other Medical Devices: Implications for FDA Regulation of Digital Health.
    Ronquillo JG; Zuckerman DM
    Milbank Q; 2017 Sep; 95(3):535-553. PubMed ID: 28895231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating the Voice of the Patient Into the Medical Device Regulatory Process Using Patient Preference Information.
    Benz HL; Saha A; Tarver ME
    Value Health; 2020 Mar; 23(3):294-297. PubMed ID: 32197723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices.
    Van Norman GA
    JACC Basic Transl Sci; 2016 Jun; 1(4):277-287. PubMed ID: 30167516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?
    Samuel AM; Rathi VK; Grauer JN; Ross JS
    Clin Orthop Relat Res; 2016 Apr; 474(4):1053-68. PubMed ID: 26584802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-computer interface devices for patients with paralysis and amputation: a meeting report.
    Bowsher K; Civillico EF; Coburn J; Collinger J; Contreras-Vidal JL; Denison T; Donoghue J; French J; Getzoff N; Hochberg LR; Hoffmann M; Judy J; Kleitman N; Knaack G; Krauthamer V; Ludwig K; Moynahan M; Pancrazio JJ; Peckham PH; Pena C; Pinto V; Ryan T; Saha D; Scharen H; Shermer S; Skodacek K; Takmakov P; Tyler D; Vasudevan S; Wachrathit K; Weber D; Welle CG; Ye M
    J Neural Eng; 2016 Apr; 13(2):023001. PubMed ID: 26924826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical Devices; Exemption From Premarket Notification: Class II Devices; Surgical Apparel. Final order.
    Food and Drug Administration, HHS
    Fed Regist; 2018 May; 83(96):22846-8. PubMed ID: 30016835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical Devices; Exemption From Premarket Notification; Class II Devices; Electric Positioning Chair. Final order.
    Food and Drug Administration, HHS
    Fed Regist; 2015 Nov; 80(224):72589-91. PubMed ID: 26595944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safe Medical Devices Act: management guidance for hospital compliance with the new FDA requirements.
    Alder HC
    Hosp Technol Ser; 1993 Oct; 12(11):1-27. PubMed ID: 10129209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical devices; exemptions from premarket notification; class II devices--FDA, Final rule.
    Fed Regist; 1998 Nov; 63(212):59222-31. PubMed ID: 10187384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory issues relating to therapies for periodontal regeneration.
    Singleton DG; Torres-Cabassa A
    Ann Periodontol; 1997 Mar; 2(1):223-8. PubMed ID: 9151556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conflicting information from the Food and Drug Administration: Missed opportunity to lead standards for safe and effective medical artificial intelligence solutions.
    Hernandez-Boussard T; Lundgren MP; Shah N
    J Am Med Inform Assoc; 2021 Jun; 28(6):1353-1355. PubMed ID: 33674865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New orthopedic devices and the FDA.
    Sheth U; Nguyen NA; Gaines S; Bhandari M; Mehlman CT; Klein G
    J Long Term Eff Med Implants; 2009; 19(3):173-84. PubMed ID: 20939777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orthopaedic joint devices: the FDA's short answers to your questions.
    Foy JR; Buch BD
    J Am Acad Orthop Surg; 2008; 16 Suppl 1():S123-8. PubMed ID: 18612007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.